Tetrahydrobiopterin Role in human umbilical vein endothelial dysfunction in maternal supraphysiological hypercholesterolemia

Leiva, Andrea, Fuenzalida, Barbara, Salsoso, Rocio, Barros, Eric, Toledo, Fernando, Gutierrez, Jaime, Pardo, Fabian and Sobrevia, Luis (2016) Tetrahydrobiopterin Role in human umbilical vein endothelial dysfunction in maternal supraphysiological hypercholesterolemia. Biochimica Et Biophysica Acta-Molecular Basis of Disease, 1862 4: 536-544. doi:10.1016/j.bbadis.2016.01.021

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
UQ435116_OA.pdf Full text (open access) application/pdf 693.55KB 0

Author Leiva, Andrea
Fuenzalida, Barbara
Salsoso, Rocio
Barros, Eric
Toledo, Fernando
Gutierrez, Jaime
Pardo, Fabian
Sobrevia, Luis
Title Tetrahydrobiopterin Role in human umbilical vein endothelial dysfunction in maternal supraphysiological hypercholesterolemia
Journal name Biochimica Et Biophysica Acta-Molecular Basis of Disease   Check publisher's open access policy
ISSN 0925-4439
Publication date 2016-04-01
Sub-type Article (original research)
DOI 10.1016/j.bbadis.2016.01.021
Open Access Status File (Author Post-print)
Volume 1862
Issue 4
Start page 536
End page 544
Total pages 9
Place of publication Amsterdam, Netherlands
Publisher Elsevier
Collection year 2017
Language eng
Formatted abstract
Maternal physiological hypercholesterolemia (MPH) allows a proper foetal development; however, maternal supraphysiological hypercholesterolemia (MSPH) associates with foetal endothelial dysfunction and early development of atherosclerosis. MSPH courses with reduced endothelium-dependent dilation of the human umbilical vein due to reduced endothelial nitric oxide synthase activity compared with MPH. Whether MSPH modifies the availability of the nitric oxide synthase cofactor tetrahydrobiopterin is unknown. We investigated whether MSPH-associated lower umbilical vein vascular reactivity results from reduced bioavailability of tetrahydrobiopterin. Total cholesterol <. 7.2 mmol/L was considered as maternal physiological hypercholesterolemia (n = 72 women) and ≥. 7.2 mmol/L as MSPH (n = 35 women). Umbilical veins rings were used for vascular reactivity assays (wire myography), and primary cultures of human umbilical vein endothelial cells (HUVECs) to measure nitric oxide synthase, GTP cyclohydrolase 1, and dihydrofolate reductase expression and activity, as well as tetrahydrobiopterin content. MSPH reduced the umbilical vein rings relaxation caused by calcitonine gene-related peptide, a phenomenon partially improved by incubation with sepiapterin. HUVECs from MSPH showed lower nitric oxide synthase activity (l-citrulline synthesis from l-arginine) without changes in its protein abundance, as well as reduced tetrahydrobiopterin level compared with MPH, a phenomenon reversed by incubation with sepiapterin. Expression and activity of GTP cyclohydrolase 1 was lower in MSPH, without changes in dihydrofolate reductase expression. MSPH is a pathophysiological condition reducing human umbilical vein reactivity due to lower bioavailability of tetrahydrobiopterin leading to lower NOS activity in the human umbilical vein endothelium.
Keyword Cholesterol
Endothelium
Foetal
Pregnancy
Tetrahydrobiopterin
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: UQ Centre for Clinical Research Publications
HERDC Pre-Audit
Admin Only - UQCCR
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Thu, 02 Feb 2017, 15:59:44 EST by Anthony Yeates on behalf of Learning and Research Services (UQ Library)